Literature DB >> 33255171

New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms.

Anna Gorrasi1, Anna Maria Petrone1, Anna Li Santi1, Mariaevelina Alfieri1, Nunzia Montuori2, Pia Ragno1.   

Abstract

The urokinase (uPA) receptor (uPAR) plays a key role in cell migration. We previously showed that uPAR-negative HEK-293 cells efficiently migrate toward serum but, after uPAR ectopic expression, migrate only in a uPAR-dependent manner. In fact, migration of uPAR-transfected HEK-293 (uPAR-293) cells is impaired by anti-uPAR antibodies, without recovery of the uPAR-independent migration mechanisms formerly active. Prostate carcinoma PC3 cells, which express high endogenous uPAR levels, migrated only through a uPAR-dependent mechanism; in fact, the silencing of uPAR expression inhibited their migration. We hypothesize a crucial role of the uPAR glycosyl-phosphatidyl-inositol (GPI) tail, which promotes uPAR partitioning to lipid rafts, in uPAR-controlled cell migration. Here, we show that removal of the uPAR GPI-tail, or lipid rafts disruption by methyl-beta-cyclodextrin impairs migration of PC3 cells, incapable of uPAR-independent migration, whereas it restores uPAR-independent migration in uPAR-293 cells. We then show that, in PC3 cells, both uPAR signaling partners, β1 integrins and receptors for formylated peptides (FPRs), partly associate with lipid rafts. Inhibition of their interaction with uPAR impairs this association and impairs cell migration. Interestingly, blocking uPAR association with FPRs also impairs β1 integrin partitioning to lipid rafts, whereas blocking its association with β1 integrins has no effect on FPRs partitioning. On these bases, we propose that uPAR controls cell migration by connecting β1 integrins and FPRs and, through its GPI tail, by driving them into lipid rafts, thus promoting pro-migratory signals. uPAR-mediated partitioning of integrins to lipid rafts is strictly dependent on uPAR association with FPRs.

Entities:  

Keywords:  FPR1; cell migration; fMLF receptors; uPAR; urokinase receptor

Mesh:

Substances:

Year:  2020        PMID: 33255171      PMCID: PMC7761155          DOI: 10.3390/cells9122531

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  33 in total

1.  The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.

Authors:  Nunzia Montuori; Katia Bifulco; Maria Vincenza Carriero; Claudio La Penna; Valeria Visconte; Daniela Alfano; Ada Pesapane; Francesca Wanda Rossi; Salvatore Salzano; Guido Rossi; Pia Ragno
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

Review 2.  The urokinase receptor and integrins in cancer progression.

Authors:  C-H Tang; Y Wei
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

Review 3.  Greasing their way: lipid modifications determine protein association with membrane rafts.

Authors:  Ilya Levental; Michal Grzybek; Kai Simons
Journal:  Biochemistry       Date:  2010-08-03       Impact factor: 3.162

4.  Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.

Authors:  Amato de Paulis; Nunzia Montuori; Nella Prevete; Isabella Fiorentino; Francesca Wanda Rossi; Valeria Visconte; Guido Rossi; Gianni Marone; Pia Ragno
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

5.  Lipid raft compartmentalization of urokinase receptor signaling in human neutrophils.

Authors:  Robert G Sitrin; Douglas R Johnson; Pauline M Pan; Donna M Harsh; Jibiao Huang; Howard R Petty; R Alexander Blackwood
Journal:  Am J Respir Cell Mol Biol       Date:  2003-08-21       Impact factor: 6.914

6.  Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions.

Authors:  Orla Cunningham; Annapaola Andolfo; Maria Lisa Santovito; Lucia Iuzzolino; Francesco Blasi; Nicolai Sidenius
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

7.  Structure and ligand interactions of the urokinase receptor (uPAR).

Authors:  Magnus Kjaergaard; Line V Hansen; Benedikte Jacobsen; Henrik Gardsvoll; Michael Ploug
Journal:  Front Biosci       Date:  2008-05-01

8.  Discovery of new small molecules targeting the vitronectin-binding site of the urokinase receptor that block cancer cell invasion.

Authors:  Vincenza Elena Anna Rea; Antonio Lavecchia; Carmen Di Giovanni; Francesca Wanda Rossi; Anna Gorrasi; Ada Pesapane; Amato de Paulis; Pia Ragno; Nunzia Montuori
Journal:  Mol Cancer Ther       Date:  2013-05-22       Impact factor: 6.261

Review 9.  Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.

Authors:  V M Baart; R D Houvast; L F de Geus-Oei; P H A Quax; P J K Kuppen; A L Vahrmeijer; C F M Sier
Journal:  EJNMMI Res       Date:  2020-07-28       Impact factor: 3.138

Review 10.  Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR.

Authors:  Nunzia Montuori; Pia Ragno
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  2 in total

1.  Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells.

Authors:  Mariaevelina Alfieri; Anna Li Santi; Luigia Meo; Valentina Giudice; Carmine Selleri; Pia Ragno
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

Review 2.  Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.

Authors:  Daniela Alfano; Paola Franco; Maria Patrizia Stoppelli
Journal:  Front Cell Dev Biol       Date:  2022-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.